A detailed overview of SARS-CoV-2 omicron: its sub-variants, mutations and pathophysiology, clinical characteristics, immunological landscape, immune escape, and …
The COVID-19 pandemic has created significant concern for everyone. Recent data from
many worldwide reports suggest that most infections are caused by the Omicron variant and …
many worldwide reports suggest that most infections are caused by the Omicron variant and …
Efficacy and safety of tixagevimab‐cilgavimab as pre‐exposure prophylaxis for COVID‐19: a systematic review and meta‐analysis
Some proportions of populations, such as immunocompromised patients and organ
transplant recipients might have inadequate immune responses to the vaccine for …
transplant recipients might have inadequate immune responses to the vaccine for …
Antiviral molecular targets of essential oils against SARS-CoV-2: A systematic review
Essential oils are potential therapeutics for coronavirus disease 2019 (COVID-19), in which
some of the volatile compounds of essential oils have been well known for their broad …
some of the volatile compounds of essential oils have been well known for their broad …
The WHO has declared the end of pandemic phase of COVID‐19: Way to come back in the normal life
Abstract The coronavirus disease 2019 (COVID‐19) pandemic has resulted in significant
global mortality and morbidity affecting millions of lives. As healthcare authorities worldwide …
global mortality and morbidity affecting millions of lives. As healthcare authorities worldwide …
Mucosal SARS-CoV-2 nanoparticle vaccine based on mucosal adjuvants and its immune effectiveness by intranasal administration
L **ao, W Yu, L Shen, W Yan, J Qi… - ACS Applied Materials & …, 2023 - ACS Publications
SARS-CoV-2 is a respiratory virus that causes significant threats to human health. Mucosal
immunity provides a first-line defense to prevent the infection of SARS-CoV-2 in the …
immunity provides a first-line defense to prevent the infection of SARS-CoV-2 in the …
COVID-19 modified mRNA “vaccines”: Lessons learned from clinical trials, mass vaccination, and the bio-pharmaceutical complex, Part 1
MN Mead, S Seneff, R Wolfinger, J Rose… - International Journal of …, 2024 - ijvtpr.com
Our understanding of COVID-19 synthetic, modified mRNA (modmRNA) products and their
public health impact has evolved substantially since December 2020. Published reports …
public health impact has evolved substantially since December 2020. Published reports …
COVID-19 pandemic sheds a new research spotlight on antiviral potential of essential oils–A bibliometric study
Background Essential oils are thought as potential therapies in managing coronavirus
disease 2019 (COVID-19). Many researchers have put their efforts to tackle the pandemic by …
disease 2019 (COVID-19). Many researchers have put their efforts to tackle the pandemic by …
[HTML][HTML] Bile acids and bile acid activated receptors in the treatment of Covid-19
Since its first outbreak in 2020, the pandemic caused by the Severe Acute Respiratory
Syndrome-Coronavirus-2 (SARS-CoV-2) has caused the death of almost 7 million people …
Syndrome-Coronavirus-2 (SARS-CoV-2) has caused the death of almost 7 million people …
Twitter-based sentiment analysis and topic modeling of social media posts using natural language processing, to understand people's perspectives regarding COVID …
This study analyzed perceptions of Indians regarding COVID-19 booster dose vaccines
using natural language processing techniques, particularly, sentiment analysis and topic …
using natural language processing techniques, particularly, sentiment analysis and topic …
COVID-19 modified mRNA “vaccines”: Lessons learned from clinical trials, mass vaccination, and the bio-pharmaceutical complex, Part 2
MN Mead, S Seneff, J Rose, R Wolfinger… - International Journal of …, 2024 - ijvtpr.com
The COVID-19 modified mRNA (modmRNA) lipid nanoparticle-based “vaccines” are not
classical antigen-based vaccines but instead prodrugs informed by gene therapy …
classical antigen-based vaccines but instead prodrugs informed by gene therapy …